Physician profile
Tabitha Andre
NPI 1164612917
$958.40
in general payments reported to CMS, 2019-2025
18 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $107 · 2021: $14.53 · 2023: $63.84 · 2024: $263 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $206.05 | 2019-2025 | |
| Abbvie INC. | $147.94 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $113.45 | 2024-2025 | Myfembree, Gemtesa |
| Organon LLC | $96.08 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $47.77 | 2019-2020 | |
| Hologic Sales and Service, LLC | $47.34 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $44.02 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $41.44 | 2024-2025 | Veozah |
| Lupin INC. | $34.63 | 2019-2020 | |
| Millicent US INC | $33.52 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Pfizer INC. | $29.90 | 2024 | |
| Merck Sharp & Dohme LLC | $29.59 | 2019 | |
| Therapeuticsmd, INC. | $23.42 | 2020 | |
| Evofem Biosciences, INC. | $14.53 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.24 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $12.10 | 2023 | |
| Avion Pharmaceuticals | $11.27 | 2019 | |
| Zyla Life Sciences, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.